Previous Article | Next Article ![]()
Journal of Bacteriology, May 2003, p. 2920-2926, Vol. 185, No. 9
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.9.2920-2926.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Molecular Cellular and Developmental Biology, The University of Michigan, Ann Arbor, Michigan 48109-1048
Received 21 August 2002/ Accepted 20 February 2003
|
|
|---|
|
|
|---|
The Ntr system is a complex regulatory cascade that senses the quality of the available nitrogen supply and ultimately results in the activation of a transcriptional activator, NTRC, when the nitrogen source is growth rate limiting (20). Many of the genes in the Ntr regulon are directly regulated by the NTRC-mediated activation of RNA polymerase bearing the unusual sigma factor
54. But some genes in the Ntr regulon are regulated indirectly, and their transcription is activated by the nitrogen assimilation control protein NAC, which activates RNA polymerase bearing the more common sigma factor
70 (4).
When NAC activates transcription, it binds to a consensus sequence often abbreviated ATA-N9-TAT (26). A search of available DNA sequence data for sequences resembling this site uncovered many such sequences within the E. coli genome (12), one of which was in the promoter region of codBA, the operon that encodes cytosine deaminase (codA) and a cytosine permease (codB). When a nac mutant of E. coli was tested for growth with cytosine as the sole nitrogen source, the nac mutant grew more slowly than the wild type (23). The presence of a NAC site in the codBA promoter region and the slow growth phenotype of a nac mutant when cytosine was the sole nitrogen course suggested that NAC was involved in the nitrogen regulation of codBA.
An analysis using microarrays to measure steady-state mRNA levels in response to physiological and genetic signals that affect nitrogen regulation has been recently reported (28). These data show that codBA expression is indeed regulated by nitrogen, that this response requires the Ntr system, and that the response also requires NAC. The experiments reported here were designed to determine whether NAC directly regulates the codBA operon or whether NAC might act indirectly.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. List of strains
|
In vitro transcription.
In vitro transcription from the codBA promoter in plasmid pCB592 was carried out essentially as described by Maquat and Reznikoff (21) by using RNA polymerase with
70 (purchased from Epicentre Technologies) and NAC (purified essentially as described by Goss and Bender [12]). [
-32P]UTP was included in the reaction mixture, and the resulting radioactive transcripts were separated by polyacrylamide gel electrophoresis and visualized by autoradiography.
Gel mobility shift assays.
DNA fragments were isolated and labeled with [
-32P]dATP by using the Klenow fragment (Roche) according to the manufacturer's instructions. Labeled DNA fragments were incubated with increasing concentrations of purified NAC protein with 50 mM Tris, pH 7.5, and 20 nM poly(d · IC) in a total volume of 5 µl. The binding mixtures were incubated for 20 min at 30°C, and after this incubation period, 1 µl of DNA loading buffer (2 mg of bromophenol blue, 2 mg of xylene cyanol, 40 mM Tris [pH 8.4], 4 mM EDTA [pH 8.0], 25% glycerol) was added. Each reaction was loaded onto a Tris-borate-EDTA 5% polyacrylamide gel, and the gel was run, treated, and exposed to film as previously described (26).
DNase I footprinting. Plasmid DNA was linearized by digestion with EcoRI or HindIII, and the resulting 3' ends were labeled with the Klenow fragment of DNA polymerase I. The labeled DNA was digested with a second restriction enzyme to generate two end-labeled fragments, one less than 20 bp and the other carrying the promoter of interest. A 7-µl sample containing about 0.2 pmol of DNA (about 500,000 cpm) was mixed with purified NAC and allowed to incubate for 30 min at room temperature. Digestion was initiated by the addition of 10-3 U of DNase I and terminated 2 min later by the addition of 7 µl of formamide, and samples were incubated at 80°C for 5 min. Samples were prepared for electrophoresis, and the digested fragments were separated by electrophoresis in polyacrylamide gels containing 7 M urea. The results were visualized by autoradiography. DNase I digestion patterns were aligned with the DNA sequence by comparison with the G and/or A+G sequencing ladders that were run on the same gels.
Construction of plasmids. The plasmid pRAC82 (a kind gift of Jan Neuhard) carries a HaeIII fragment of E. coli DNA cloned into the SmaI site in pUC19. The full-length codBA promoter region, extending from positions -120 to +67 relative to the start site of transcription, was subcloned as an EcoRI-BamHI fragment into the lacZ expression vector pRJ800 (3), resulting in plasmid pCB1375. Plasmid pCB910 contains a shorter fragment extending from positions -83 to +67 that was generated by PCR. Plasmid pCB911 was constructed exactly as was pCB910, except that the upstream primer contained an A-to-C change in the first nucleotide of the NAC-binding sequence. Thus, plasmid pCB911 is identical to pCB910 except that pCB910 carries the sequence ATA-N9-TAT and pCB911 carries CTA-N9-TAT. Plasmids pCB816 and pCB864 (carrying the longer and shorter promoter regions, respectively) were used for DNase I footprinting. Plasmid pCB816 carries an EcoRI-HindIII fragment from positions -120 to +67 cloned into pBC KS+. Plasmid pCB864 carries the region from positions -83 to +67 cloned as an EcoRI-BamHI fragment in pBC KS+. Thus, pCB816 and pCB864 are in opposite orientations in pBC KS+. Plasmid pCB592 carries the full-length codBA promoter region (positions -120 to +67) cloned upstream from the strong transcription terminator in pTE103 (9).
A cytosine deaminase gene from K. pneumoniae was initially cloned by using the in vivo method based on phage Mu and described by Groisman and Casadaban (15). The resulting plasmid, pCB619, contained about 5 kb of K. pneumoniae DNA inserted into pEG5005. Plasmid pCB619 allowed strain YMC10 (
cod-lac) to grow with cytosine as the sole nitrogen source. A 7.4-kb HindIII fragment from pCB619 (containing the kanamycin resistance element from pEG5005 as well as the codA gene from K. pneumoniae) was subcloned into pGB2 (7), resulting in pCB628. A 6.6kb SacI-EcoRI fragment from pCB628 was then subcloned into pBluescript (pBS KS-), resulting in pCB630.
|
|
|---|
|
View this table: [in a new window] |
TABLE 2. Sensitivity to 5-fluorocytosine
|
Cytosine deaminase in K. pneumoniae. Our laboratory has a longstanding interest in nitrogen regulation in K. pneumoniae where nitrogen-regulated genes are more numerous and often more tightly regulated than those of E. coli. Therefore, we examined the regulation of cytosine deaminase expression in K. pneumoniae. Wild-type K. pneumoniae strain KC2668 was much more sensitive to fluorocytosine under nitrogen-limiting conditions than under nitrogen excess (Table 2). Moreover, a nac mutation abolished the increased sensitivity (Table 2, strain KC2725), suggesting that K. pneumoniae has a NAC-regulated cytosine deaminase.
Surprisingly, E. coli and K. pneumoniae differed in their response to the presence of hypoxanthine. In E. coli, the presence of hypoxanthine in the medium reduced codBA expression because codBA is under the control of the purR repressor protein in addition to control by NAC (1). As a result, hypoxanthine reduced the sensitivity of E. coli to fluorocytosine (Table 2, strain W3110). In contrast, hypoxanthine increased the sensitivity of K. pneumoniae to fluorocytosine (Table 2, strain KC2668).
NAC-dependent activation of codBA expression in vivo. The data in Table 3 show that cytosine deaminase formation is derepressed about threefold by nitrogen-limited growth in E. coli (strain W3110). This confirms the earlier data of Anderson et al. (1) by using a different assay. This derepression was abolished in the nac mutant, strain EB3366. In strain EB3846, which carries the IPTG-inducible nac gene on pPC36, the addition of IPTG led to a threefold induction of cytosine deaminase even in nitrogen-excess medium. Thus, NAC was necessary for the derepression of cytosine deaminase formation.
|
View this table: [in a new window] |
TABLE 3. Cytosine deaminase activity and ß-galactosidase expression from codB-lacZ fusions
|
![]() View larger version (16K): [in a new window] |
FIG. 1. DNA sequence of the codBA promoter region showing key features. The DNA sequence is as found in pRAC82. Small letters represent vector DNA; capital letters represent E. coli DNA. Boxed nucleotides are the NAC consensus sequence. Over- and underscoring show the extent of the DNase I footprint of NAC on the top and bottom strands of this fragment (Fig. 3 and data not shown). The arrowhead indicates the strong hypersensitive site. The letters with a line through them represent the segment that was deleted (replaced) in the shorter promoter in pCB910 and pCB911. The bold letters at position +1 are the start sites of transcription (8). Underlined sequences are putative -10 and -35 regions, and GTG is the start site of the codB-coding sequence. The C above the A at position -66 indicates the nucleotide changed in the construction of pCB911 from pCB910.
|
Plasmid pCB911 with its defective NAC site was used in the same three tests as pCB910. Under nitrogen-limiting conditions, a wild-type strain showed no more cod-lac expression than a strain carrying the nac-28 mutation (Table 3, strains EB3880 and EB3881). The Ntr constitutive strain showed no more cod-lac expression than the nac-28 strain (Table 3, strains EB3878 and EB3879). Finally, even IPTG induction of the nac gene on pPC36 resulted in only a slight (about 30%) increase in cod-lac expression. Thus, the ATA-N9-TAT sequence thought to be important for NAC binding was necessary for the NAC-mediated activation of codBA transcription in vivo.
NAC binds to the codBA promoter. The importance of the ATA-N9-TAT sequence for NAC binding was confirmed by gel mobility shift analysis and by DNase I footprinting. Figure 2 shows that a DNA fragment containing the mutant codBA promoter from pCB911 was defective in NAC binding, whereas comparable wild-type fragments from pRAC82 and pCB910 did bind NAC. However, the fragments from pRAC82 and pCB910 showed different patterns of mobility shift by NAC. In both cases, two specific shifts were detected. When the longer fragment (positions -120 to +67) was used, the slower-migrating band predominated. When the shorter fragment was used, the faster-migrating band predominated. Curiously, the only shift detected with the mutant fragment was the slower-migrating one, which, though weak, was about as strong as the comparable band in the fragment from pCB910 (Fig. 2, lanes 10 and 15).
![]() View larger version (32K): [in a new window] |
FIG. 2. Gel mobility shift assay of the interaction of NAC with the codBA promoter region. Each lane contains about 100,000 cpm of 32P-end-labeled DNA. Lanes 1 through 5 (longer promoter), the EcoRI-HindIII fragment from pRAC82 containing promoter DNA from positions -120 to +67; lanes 6 through 10 (shorter promoter), an EcoRI-BamHI fragment from pCB910 containing promoter DNA from positions -83 to +67; lanes 11 through 15 (mutant promoter), an EcoRI-BamHI fragment from pCB911 containing the same promoter DNA (positions -83 to +67) but with an A-to-C mutation in the NAC-binding site. In each set of five, NAC was absent from the first lane and the remaining four samples were incubated with 7, 26, 66, or 132 ng of NAC before electrophoresis.
|
![]() View larger version (72K): [in a new window] |
FIG. 3. DNase I protection assay of the codBA promoter. Lanes 1 through 3 show the top strand of pCB816 (labeled at the HindIII site), which contained the longer promoter fragment. Lanes 6 through 8 show the DNase I footprint of NAC on pCB864 (labeled at the HindIII site) which contained the shorter promoter fragment. Lane 4 contained the G ladder, and lane 5 contained the no-DNase I control. Lanes 1, 2, and 3 contained 0, 0.1, and 0.5 µg of NAC, respectively. Lanes 6, 7, and 8 contained 0, 0.4, and 0.8 µg of NAC, respectively. Protected regions are indicated with the black bar, and hypersensitive sites are marked with black arrows. The open bar and arrowhead indicate the protected region and hypersensitive site seen in the longer codBA promoter construct, respectively. For comparison, the protected sequences are indicated in Fig. 1.
|
![]() View larger version (74K): [in a new window] |
FIG. 4. In vitro transcription from the codBA promoter. The DNA template was supercoiled plasmid pCB592. The reactions in lanes 1 through 6 contained purified RNA polymerase from E. coli. Lane 1 contained no NAC. Lanes 2 through 4 contained 0.1, 0.2, and 1.0 µg of NAC derived from K. pneumoniae, respectively. Lanes 5 and 6 contained 1 µg of NAC (from K. pneumoniae and E. coli, respectively) prepared as an MBP-NAC fusion protein and cleaved with factor Xa to release active NAC immediately before addition to the reaction mixture. Lane 7 contained labeled DNA size standards of 210, 245, 400, and 510 bp. The arrow indicates the runoff transcript from the codB promoter.
|
Two cytosine deaminase genes in K. pneumoniae.
We sought a clone of the gene for cytosine deaminase from K. pneumoniae for comparative study. The in vivo cloning procedure of Groisman and Casadaban (15) yielded plasmid pCB619 (moderate copy number). The E. coli
cod-lac strain, YMC10, carrying this plasmid (strain EB3246) was able to grow with cytosine as the sole nitrogen source and was sensitive to fluorocytosine. A DNA fragment from pCB619 was subcloned into a low-copy-number plasmid (pCB628) and a high-copy-number plasmid (pCB630) (see Materials and Methods). Plasmid pCB628 allowed the E. coli
cod-lac strain DH5
to grow with cytosine as sole nitrogen source. Plasmid pCB630 conferred cytosine growth and fluorocytosine sensitivity on strain EB3264 (DH5
/pCB630), but it also made this strain unable to grow on minimal medium unless supplemented with cytosine. Enzyme assays confirmed that strain EB3264 produced a cytosine deaminating activity and that nitrogen limitation led to a fivefold derepression of this cytosine deaminase (Table 3). Thus the cloned fragment contained all the information to produce cytosine deaminase whose formation was regulated by nitrogen.
The DNA sequence of two contiguous BamHI fragments from pCB630 was determined, representing about 5.8 kb of DNA. This sequence was compared to the genomic sequence of K. pneumoniae strain MGH78578 that was determined by the Genome Sequencing Center at Washington University at St. Louis (http://www.genome.wustl.edu) and was identical except for 1 nucleotide. This 5.8-kb region contained a number of open reading frames (ORFs), of which three were of particular interest. These three ORFs span a continuous sequence of 3,657 bp such that the termination codon of each ORF (TGA in each case) overlapped the initiation codon of the next ORF. When the deduced amino acid sequences of these three ORFs were compared to the sequences of deduced E. coli proteins, the first ORF showed similarity to the codB (cytosine permease) protein and the third ORF showed strong similarity to the codA (cytosine deaminase) protein. The deduced amino acid sequence of the intervening ORF (predicted to be 411 amino acids long) showed no strong similarity to any E. coli protein. Thus, the organization of this putative operon differs from the codBA operon of E. coli.
Surprisingly, when the codA gene from E. coli was compared to the genomic sequence of K. pneumoniae strain MGH78578, a second unlinked gene that was even more similar to E. coli codA than was the ortholog on pCB630 was found. Perhaps this may explain another peculiar difference between E. coli and K. pneumoniae.
|
|
|---|
Many of the previous examples of promoters strongly activated by NAC have a NAC-binding site centered at -64 relative to the start site of transcription (4). An analysis of NAC-mediated activation by using the lacZ promoter region confirmed that the strongest activation occurred when the NAC site was centered at position -64 (25). However, significant activation (about threefold) was observed when the NAC site was centered at position -42, -52, or -54. Consistent with these artificial constructs, we found that the alanine utilization operon (dadAB) from K. pneumoniae is activated about threefold and has a NAC site centered at position -44 (17). However, no activation of the lacZ promoter was seen when the NAC-binding site of the artificial constructs was moved 5 bp from these sites to position -47, -49, or -59 (25). Yet NAC can activate codBA transcription from a site centered at position -59. Such a location should put the NAC binding on the opposite side of the DNA helix from all other known NAC activation sites.
The location of the NAC-binding site at cod is not its only unusual feature; the architecture of the site is also unusual. The consensus sequence for NAC-activated promoters is ATA-N9-TAT. At these sites, NAC generates a simple footprint of about 26 bp with the consensus sequence located at the center. Occasionally, a slight increase in DNase I sensitivity is seen just at the promoter-proximal edge of the footprint but it is always very slight at best. The consensus-binding site for NAC-repressible promoters (gdhA and nac) includes ATA-N9-GAT (13). At these sites, NAC has a complex footprint consisting of a core footprint of 26-bp that includes the ATA-N9-GAT sequence, a region of strong DNase I hypersensitivity, and an extended footprint of similar size covering a nucleotide sequence that bears no recognizable similarity to the known consensus sequences for NAC binding. At nac, the extended footprint is strong and has distinct endpoints (10). At gdhA, the extended footprint is weaker and its endpoint is less distinct (13). In addition, gel mobility shift assays at gdhA show two retarded species in contrast to the single species seen at activatable promoters (18). The extended footprints seen in DNase I footprints and the slower-migrating bands seen in gel shifts at gdhA and codBA suggest the presence of a second NAC dimer (possibly NAC tetramers) bound to the DNA. Thus, the footprints and gel mobility shift pattern of NAC at codBA resemble those of NAC-repressible promoters more closely than other NAC-activatable promoters. The significance of this observation is unclear, especially since replacement of part of the extended footprint with vector DNA sequences abolished the complex footprint and gel mobility shift patterns without abolishing the NAC-mediated activation.
One other feature of the NAC site at codBA is its extreme AT richness. The codBA promoter region (positions -120 to +67) includes five runs of T5 or T6 as well as a run of A6 that lies in the center of the NAC-binding site. In fact, the 15 bp consensus region for NAC binding at codBA contains only A's and T's.
The identification of two putative cytosine deaminase genes in K. pneumoniae was unexpected. The gene that was cloned in pCB630 certainly encodes a cytosine deaminase. First, it allows a
cod-lac deletion of E. coli to use cytosine as its sole nitrogen source. Second, it confers sensitivity to fluorocytosine on strains that carry it. And third, cell extracts of strains that carry this gene contain an activity that can release ammonia from cytosine. We have no direct evidence that the other codA ortholog is an authentic cytosine deaminase gene, but its strong similarity to the E. coli codA gene makes it likely.
The codBA operon of E. coli is part of the "insertion bubble" that distinguishes the lacZYA region of E. coli from other enteric bacteria (5). Thus, one may ask where the codA genes of K. pneumoniae lie. The ORFs on pCB630 give no clue to this question. However, a comparison of the genes on the same DNA segment of the K. pneumoniae genomic sequence strongly suggests that the codA ortholog on pCB630 lies at a position analogous to min 13 of the E. coli genetic map and that the other codA ortholog lies at min 75. About 15 kb from the codA ortholog found on pCB630 is a sequence of ORFs that are orthologous to E. coli fepB, entC, entE, entA, cstA, and ybdH (in that order and transcribed convergently toward the 3' end of codA). That places this ortholog near min 13. The other codA ortholog appears to be neatly inserted between the nirB gene (part of the nitrite reductase operon) and an unidentified ORF (orf383). In E. coli, orf393 and nirB are separated by 262 bp and are transcribed in the same direction. In K. pneumoniae, the codA ortholog is 39 bp downstream from orf393, 239 bp upstream from nirB, and transcribed in the direction opposite both of them. This places the other codA ortholog at min 75, near the crp gene.
The regulation of cytosine deaminase formation in E. coli is quite complex. This is expected because the deamination of cytosine can lead to an imbalance in pyrimidine pools. The threefold increase in cytosine deaminase formation mediated by NAC has a profound effect on fluorocytosine sensitivity. The 10-fold increase seen when the high-copy-number clone pCB630 was present seems to have led to such rapid degradation of endogenous cytosine that the cells were unable to synthesize enough cytosine to allow growth and could grow only when an exogenous source was provided. In other words, even small changes in expression can have serious consequences and therefore, tight regulation is necessary.
This work was supported by Public Health Service grant GM47156 from the National Institutes of Health to R.A.B.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»